Curcumin ingestion and exercise training improve vascular endothelial function in postmenopausal women

Nutrition Research

Volumn 32, Issue 10, 2012, Pages 795-799

  Akazawa, Nobuhiko ^a   Choi, Youngju ^a   Miyaki, Asako ^a   Tanabe, Yoko ^a   Sugawara, Jun ^b   Ajisaka, Ryuichi ^a   Maeda, Seiji ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Flow mediated dilation; Lifestyle modification; Menopause; Physical activity; Turmeric; Women

Indexed keywords

CURCUMIN; THERACURMIN; UNCLASSIFIED DRUG;

ADULT; AEROBIC EXERCISE; ARTICLE; BLOOD FLOW; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; DRUG EFFECT; EXERCISE INTENSITY; FEMALE; FLOW MEASUREMENT; HUMAN; HUMAN EXPERIMENT; LIFESTYLE MODIFICATION; NORMAL HUMAN; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT DURATION; VASCULAR ENDOTHELIUM; VASODILATATION;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CURCUMA; CURCUMIN; ENDOTHELIUM, VASCULAR; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; POSTMENOPAUSE; VASODILATION;

CURCUMA LONGA;

EID: 84869048646     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.09.002     Document Type: Article

References (30)

1. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991, 43:109-142.
2. Thijssen D.H., Black M.A., Pyke K.E., Padilla J., Atkinson G., Harris R.A., et al. Assessment of flow-mediated dilation in humans: a methodological and physiological guideline. Am J Physiol Heart Circ Physiol 2011, 300:H2-H12.
3. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., Georgakopoulos D., Robinson J., Deanfield J.E. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994, 24:471-476.
4. Gates P.E., Boucher M.L., Silver A.E., Monahan K.D., Seals D.R. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression. J Appl Physiol 2007, 102:63-71.
5. Taddei S., Virdis A., Ghiadoni L., Mattei P., Sudano I., Bernini G., et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996, 28:576-582.
6. Gavin K.M., Seals D.R., Silver A.E., Moreau K.L. Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women. J Clin Endocrinol Metab 2009, 94:3513-3520.
7. La Vecchia C. Sex hormones and cardiovascular risk. Hum Reprod 1992, 7:162-167.
8. DeSouza C.A., Shapiro L.F., Clevenger C.M., Dinenno F.A., Monahan K.D., Tanaka H., et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 2000, 102:1351-1357.
9. Taddei S., Galetta F., Virdis A., Ghiadoni L., Salvetti G., Franzoni F., et al. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes. Circulation 2000, 101:2896-2901.
10. Yoshizawa M., Maeda S., Miyaki A., Misono M., Choi Y., Shimojo N., et al. Additive beneficial effects of lactotripeptides intake with regular exercise on endothelium-dependent dilatation in postmenopausal women. Am J Hypertens 2010, 23:368-372.
11. Herrera M.D., Mingorance C., Rodríguez-Rodríguez R., Alvarez de Sotomayor M. Endothelial dysfunction and aging: an update. Ageing Res Rev 2010, 9:142-152.
12. Donato A.J., Black A.D., Jablonski K.L., Gano L.B., Seals D.R. Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell 2008, 7:805-812.
13. Csiszar A., Ungvari Z., Edwards J.G., Kaminski P., Wolin M.S., Koller A., et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 2002, 90:1159-1166.
14. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008, 75:787-809.
15. Gupta S.C., Patchva S., Koh W., Aggarwal B.B. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol 2012, 39:283-299.
16. Gupta S.C., Prasad S., Kim J.H., Patchva S., Webb L.J., Priyadarsini I.K., et al. Multitargeting by curcumin as revealed by molecular interaction studies. Nat Prod Rep 2011, 28:1937-1955.
17. Cho J.W., Lee K.S., Kim G.W. Curcumin attenuate the expression of IL-1β, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cell; NF-kB and MAPKs as potential upstream targets. Int J Mol Med 2007, 19:469-474.
18. Quiles J.L., Mesa M.D., Ramírez-Tortosa C.L., Aguilera C.M., Battiono M., Gil A., et al. Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 2002, 22:1225-1231.
19. Wongcharoen W., Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol 2009, 133:145-151.
20. Kanai M., Imaizumi A., Otsuka Y., Sasaki H., Hashiguchi M., Tsujiko K., et al. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol 2012, 69:65-70.
21. Sugawara J., Akazawa N., Miyaki A., Choi Y., Tanabe Y., Imai T., et al. Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women: pilot study. Am J Hypertens 2012, 25:651-656.
22. Sasaki H., Sunagawa Y., Takahashi K., Imaizumi A., Fukuda H., Hashimoto T., et al. Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull 2011, 34:660-665.
23. Yoshizawa M., Maeda S., Miyaki A., Misono M., Choi Y., Shimojo N., et al. Additive beneficial effects of lactotripeptodes and aerobic exercise on arterial compliance in postmenopausal women. Am J Physiol Heart Circ Physiol 2009, 297:H1899-H1903.
24. Kawano N., Emoto M., Mori K., Yamazaki Y., Urata H., Tsuchikura S., et al. Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients. J Atheroscler Thromb 2011, [In press].
25. Miyaki A., Maeda S., Otsuki T., Ajisaka R. Plasma pentraxin 3 concentration increases in endurance-trained men. Med Sci Sports Exerc 2011, 43:12-17.
26. Sharma R.A., Gescher A.J., Steward W.P. Curcumin: the story so far. Eur J Cancer 2005, 41:1955-1968.
27. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78:2081-2087.
28. Jiang J., Wang W., Sun Y.J., Hu M., Li F., Zhu D.Y. Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur J Pharmacol 2007, 561:54-62.
29. Eskurza I., Monahan K.D., Robinson J.A., Seals D.R. Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J Physiol 2004, 556:315-324.
30. He Z.Y., Shi C.B., Wen H., Li F.L., Wang B.L., Wang J. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Invest 2011, 29:208-213.